{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:11:34Z","timestamp":1780726294349,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK112771"],"award-info":[{"award-number":["R01 DK112771"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK114075"],"award-info":[{"award-number":["R01 DK114075"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK49587"],"award-info":[{"award-number":["R01 DK49587"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.clinthera.2020.10.006","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T04:18:01Z","timestamp":1608265081000},"page":"17-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Psychotherapy and Medications for Eating Disorders: Better Together?"],"prefix":"10.1016","volume":"43","author":[{"given":"Deborah L.","family":"Reas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Grilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.10.006_bib1","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.clinthera.2020.10.006_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12916-020-1495-2","article-title":"Mental, behavioral and neurodevelopmental disorders in the ICD-11: an international perspective on key changes and controversies","volume":"18","author":"Stein","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2020.10.006_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2018.03.014","article-title":"Prevalence and correlates of DSM-5-defined eating disorders in a nationally representative sample of U.S. adults","volume":"84","author":"Udo","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/eat.23004","article-title":"Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States","volume":"52","author":"Udo","year":"2019","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.clinthera.2020.10.006_bib5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12916-019-1352-3","article-title":"Suicide attempts in US adults with lifetime DSM-5 eating disorders","volume":"17","author":"Udo","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2020.10.006_bib6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.mayocp.2019.02.030","article-title":"Rates of help-seeking in US adults with lifetime DSM-5 eating disorders: prevalence across diagnoses and differences by sex and ethnicity\/race","volume":"94","author":"Coffino","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2020.10.006_bib7","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1192\/bjp.bp.110.089664","article-title":"Long-term efficacy of psychological treatments for binge eating disorder","volume":"200","author":"Hilbert","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib8","article-title":"Psychopharmacologic treatment of eating disorders: emerging findings","volume":"35","author":"McElroy","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.clinthera.2020.10.006_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1037\/0003-066X.62.3.199","article-title":"Psychological treatment of eating disorders","volume":"62","author":"Wilson","year":"2007","journal-title":"Am Psychol"},{"key":"10.1016\/j.clinthera.2020.10.006_bib10","series-title":"Practice Guidelines for the Treatment of Patients with Eating Disorders","year":"2006"},{"key":"10.1016\/j.clinthera.2020.10.006_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11920-016-0696-z","article-title":"Combining pharmacological and psychological treatments for binge eating disorder: current status, limitations, and future directions","volume":"18","author":"Grilo","year":"2016","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.clinthera.2020.10.006_bib12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1176\/ajp.155.4.548","article-title":"Does fluoxetine augment the inpatient treatment of anorexia nervosa?","volume":"155","author":"Attia","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib13","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/jama.295.22.2605","article-title":"Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial","volume":"295","author":"Walsh","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2020.10.006_bib14","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.2008.07121900","article-title":"Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial","volume":"165","author":"Bissada","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/YIC.0b013e328080ca31","article-title":"Olanzapine therapy in anorexia nervosa: psychobiological effects","volume":"22","author":"Brambilla","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2020.10.006_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1176\/ajp.149.1.82","article-title":"Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison","volume":"149","author":"Agras","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1192\/bjp.162.5.597","article-title":"A\u00a0placebo-controlled trial of d-fenfluramine in bulimia nervosa","volume":"162","author":"Fahy","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0005-7967(97)00041-7","article-title":"A\u00a0randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome","volume":"35","author":"Goldbloom","year":"1997","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.clinthera.2020.10.006_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0005-7967(94)90082-5","article-title":"Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa","volume":"32","author":"Leitenberg","year":"1994","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.clinthera.2020.10.006_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1192\/bjp.bp.110.082172","article-title":"Stepped care and cognitive-behavioural therapy for bulimia nervosa: randomised trial","volume":"198","author":"Mitchell","year":"2011","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/ajp.154.4.523","article-title":"Medication and psychotherapy in the treatment of bulimia nervosa","volume":"154","author":"Walsh","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00004714-200106000-00008","article-title":"The relative efficacy of fluoxetine and manual-based self-help in the treatment of outpatients with bulimia nervosa","volume":"21","author":"Mitchell","year":"2001","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2020.10.006_bib23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1176\/appi.ajp.161.3.556","article-title":"Treatment of bulimia nervosa in a primary care setting","volume":"161","author":"Walsh","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/erv.452","article-title":"Cognitive-behavioural, fluoxetine and combined treatment for bulimia nervosa: short- and long-term results","volume":"10","author":"Jacobi","year":"2002","journal-title":"Eur Eat Disord Rev"},{"key":"10.1016\/j.clinthera.2020.10.006_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/00048679709065073","article-title":"Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine?","volume":"31","author":"Beumont","year":"1997","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-1014424","article-title":"Fluoxetine versus placebo: a double-blind study with bulimic inpatients undergoing intensive psychotherapy","volume":"24","author":"Fichter","year":"1991","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/archpsyc.1990.01810140049008","article-title":"A\u00a0comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa","volume":"47","author":"Mitchell","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib28","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.4088\/JCP.v68n0901","article-title":"Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder","volume":"68","author":"Claudino","year":"2007","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib29","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/oby.2005.208","article-title":"Effect of orlistat in obese patients with binge eating disorder","volume":"13","author":"Golay","year":"2005","journal-title":"Obes Res"},{"key":"10.1016\/j.clinthera.2020.10.006_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0005-7894(05)80285-0","article-title":"Weight loss, cognitive-behavioral, and desipramine treatments in binge eating disorder: an additive design","volume":"25","author":"Agras","year":"1994","journal-title":"Behav Ther"},{"key":"10.1016\/j.clinthera.2020.10.006_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-108X(199911)26:3<231::AID-EAT1>3.0.CO;2-6","article-title":"Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study","volume":"26","author":"Laederach-Hofmann","year":"1999","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.clinthera.2020.10.006_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000056270","article-title":"Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study","volume":"70","author":"Ricca","year":"2001","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.clinthera.2020.10.006_bib33","first-page":"23","article-title":"Zonisamide combined with cognitive behavioral therapy in binge eating disorder: a one-year follow-up study","volume":"6","author":"Ricca","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.clinthera.2020.10.006_bib34","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/oby.2005.126","article-title":"Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder","volume":"13","author":"Devlin","year":"2005","journal-title":"Obes Res"},{"key":"10.1016\/j.clinthera.2020.10.006_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2004.11.002","article-title":"Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison","volume":"57","author":"Grilo","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.biopsych.2005.03.001","article-title":"Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Grilo","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brat.2013.01.002","article-title":"Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino\/as","volume":"51","author":"Grilo","year":"2013","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.clinthera.2020.10.006_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1037\/amp0000534","article-title":"Randomized controlled trial testing the effectiveness of adaptive \"SMART\" stepped-care treatment for adults with binge-eating disorder comorbid with obesity","volume":"75","author":"Grilo","year":"2020","journal-title":"Am Psychol"},{"key":"10.1016\/j.clinthera.2020.10.006_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brat.2014.04.002","article-title":"Treatment of binge eating in racially and ethnically diverse obese patients in primary care: randomized placebo-controlled clinical trial of self-help and medication","volume":"58","author":"Grilo","year":"2014","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.clinthera.2020.10.006_bib40","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1017\/S0033291718003525","article-title":"Efficacy of psychotherapies and pharmacotherapies for bulimia nervosa","volume":"49","author":"Svaldi","year":"2019","journal-title":"Psychol Med"},{"key":"10.1016\/j.clinthera.2020.10.006_bib41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/YCO.0000000000000358","article-title":"Pharmacotherapy of eating disorders","volume":"30","author":"Davis","year":"2017","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib42","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/oby.2007.203","article-title":"Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up","volume":"15","author":"Devlin","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.clinthera.2020.10.006_bib43","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1037\/a0030061","article-title":"12-Month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder","volume":"80","author":"Grilo","year":"2012","journal-title":"J\u00a0Consult Clin Psychol"},{"key":"10.1016\/j.clinthera.2020.10.006_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/oby.22975","article-title":"Randomized controlled trial of behavioral weight loss and stepped care for binge-eating disorder: 12-month follow-up","author":"Grilo","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.clinthera.2020.10.006_bib45","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/npp.2015.275","article-title":"Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: results of two pivotal phase 3 randomized controlled trials","volume":"41","author":"McElroy","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2020.10.006_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","article-title":"Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial","volume":"72","author":"McElroy","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clinthera.2020.10.006_bib47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/eat.22518","article-title":"Predictors of treatment outcome in individuals with eating disorders: a systematic review and meta-analysis","volume":"49","author":"Vall","year":"2016","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.clinthera.2020.10.006_bib48","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1037\/0022-006X.67.4.451","article-title":"Psychological versus pharmacological treatments of bulimia nervosa: predictors and processes of change","volume":"67","author":"Wilson","year":"1999","journal-title":"J\u00a0Consult Clin Psych"},{"key":"10.1016\/j.clinthera.2020.10.006_bib49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1037\/a0027001","article-title":"Predictors and moderators of response to cognitive behavioral therapy and medication for the treatment of binge eating disorder","volume":"80","author":"Grilo","year":"2012","journal-title":"J\u00a0Consult Clin Psych"},{"key":"10.1016\/j.clinthera.2020.10.006_bib50","unstructured":"Lydecker JA, Grilo CM. Psychiatric Comorbidity as a Predictor and Moderator of Binge-Eating Disorder Treatment Outcomes: An Analysis of Aggregated Randomized Controlled Trials. Manuscript under review."},{"key":"10.1016\/j.clinthera.2020.10.006_bib51","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1037\/0022-006X.74.3.602","article-title":"Rapid response to treatment for binge eating disorder","volume":"74","author":"Grilo","year":"2006","journal-title":"J\u00a0Consult Clin Psych"},{"key":"10.1016\/j.clinthera.2020.10.006_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1037\/a0038635","article-title":"Predicting meaningful outcomes to medication and self-help treatments for binge-eating disorder in primary care: the significance of early rapid response","volume":"83","author":"Grilo","year":"2015","journal-title":"J\u00a0Consult Clin Psychol"},{"key":"10.1016\/j.clinthera.2020.10.006_bib53","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0033291711001875","article-title":"Rapid response predicts 12-month post-treatment outcomes in binge-eating disorder: theoretical and clinical implications","volume":"42","author":"Grilo","year":"2012","journal-title":"Psychol Med"},{"key":"10.1016\/j.clinthera.2020.10.006_bib54","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/jamapsychiatry.2017.1889","article-title":"Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized clinical trial","volume":"74","author":"Hudson","year":"2017","journal-title":"JAMA Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820304744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820304744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:53:36Z","timestamp":1758963216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291820304744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0149291820304744"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.10.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotherapy and Medications for Eating Disorders: Better Together?","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}